Novavax (NVAX) Reschedules Investor, Analyst Meeting; Wants to Finalize Resolve Trial Data
Tweet Send to a Friend
Novavax, Inc., (Nasdaq: NVAX) announced it has rescheduled its 4th annual Investor and Analyst Meeting. The Company will host an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
